Your browser doesn't support javascript.
loading
Molecular Residual Disease in Breast Cancer: Detection and Therapeutic Interception.
Medford, Arielle J; Moy, Beverly; Spring, Laura M; Hurvitz, Sara A; Turner, Nicholas C; Bardia, Aditya.
Affiliation
  • Medford AJ; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Moy B; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Spring LM; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
  • Hurvitz SA; University of California Los Angeles, David Geffen School of Medicine, Los Angeles, California.
  • Turner NC; The Royal Marsden NHS Foundation Trust, Breast Cancer Now Research Centre, The Institute of Cancer Research, London, United Kingdom.
  • Bardia A; Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, Massachusetts.
Clin Cancer Res ; 29(22): 4540-4548, 2023 11 14.
Article in En | MEDLINE | ID: mdl-37477704
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Circulating Tumor DNA Type of study: Diagnostic_studies / Screening_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Circulating Tumor DNA Type of study: Diagnostic_studies / Screening_studies Limits: Female / Humans Language: En Journal: Clin Cancer Res Journal subject: NEOPLASIAS Year: 2023 Document type: Article Country of publication: United States